Bulletin from Moberg Pharma´s Extraordinary General Meeting on 3 May 2022
STOCKHOLM, 3 May 2022. Moberg Pharma AB (publ)’s (OMX: MOB) (“Moberg Pharma” or the “Company”) Extraordinary General Meeting took place today. The Extraordinary General Meeting resolved as set out below.Approval of the Board of Directors decision on a rights issueThe Extraordinary General Meeting resolved to approve the Board of Directors’ resolution on 8 April 2022 to issue ordinary shares with preferential rights for the current shareholders in the Company. According to the terms for the rights issue determined by the Board of Directors, as announced on 8 April 2022, each share in the